Search results
Results From The WOW.Com Content Network
Cryopreservation or cryoconservation is a process where biological material - cells, tissues, or organs - are frozen to preserve the material for an extended period of time. [1] At low temperatures (typically −80 °C (−112 °F) or −196 °C (−321 °F) using liquid nitrogen ) any cell metabolism which might cause damage to the biological ...
Technicians preparing a body for cryopreservation in 1985. Cryonics (from Greek: κρύος kryos, meaning "cold") is the low-temperature freezing (usually at −196 °C or −320.8 °F or 77.1 K) and storage of human remains in the hope that resurrection may be possible in the future.
Semen, embryos, oocytes, somatic cells, nuclear DNA, and other types of biomaterial such as blood and serum can be stored using cryopreservation, in order to preserve genetic materials. [ 3 ] [ 4 ] The primary benefit of cryoconservation is the ability to save germplasms for extended periods of time, therefore maintaining the genetic diversity ...
Aldehyde-stabilized cryopreservation is a new technique for cryopreservation first demonstrated in 2016 by Robert L. McIntyre and Gregory Fahy at the cryobiology research company 21st Century Medicine, Inc.
Oocyte cryopreservation is a procedure to preserve a woman's eggs . The technique is often used to delay pregnancy . At the time pregnancy is desired, the eggs can be thawed, fertilized, and transferred to the uterus as embryos .
The Cryonics Institute also specializes in Human Cryostasis, DNA/Tissue Freezing, Pet Cryopreservation, and Memorabilia Storage. [12] [13] The cryonics institute finances itself through membership dues and donations. The cost for cryopreservation is less than $30,000 but the total costs including logistics might add up to more than $100,000.
Never in a million years did I think I was going to write about animal sperm. But here we are.
Cryopreservation of ovarian tissue is of interest to women who want fertility preservation beyond the natural limit, or whose reproductive potential is threatened by cancer therapy, [1] for example in hematologic malignancies or breast cancer. [2]